Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0909
-0.0026 (-2.76%)
At close: Oct 7, 2025
Windtree Therapeutics Market Cap
Windtree Therapeutics has a market cap or net worth of $3.14 million as of October 7, 2025. Its market cap has decreased by -39.79% in one year.
Market Cap
3.14M
Enterprise Value
10.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since November 26, 1997, Windtree Therapeutics's market cap has decreased from 4.17B to 3.14M, a decrease of -99.92%. That is a compound annual growth rate of -22.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 6, 2025 | 3.14M | -18.58% |
Dec 31, 2024 | 3.86M | 4.27% |
Dec 29, 2023 | 3.70M | -43.61% |
Dec 30, 2022 | 6.56M | -85.53% |
Dec 31, 2021 | 45.36M | -47.74% |
Dec 31, 2020 | 86.80M | -50.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elite Pharmaceuticals | 686.89M |
Glass House Brands | 644.95M |
Veradigm | 511.83M |
Northwest Biotherapeutics | 382.92M |
Nika Pharmaceuticals | 333.67M |
CytoDyn | 326.79M |
American Oncology Network | 281.53M |
Silence Therapeutics | 236.17M |